Thyroid Eye Disease TED Market Size
Market Size in USD Bn
CAGR6.1%
| Study Period | 2025-2032 |
| Base Year of Estimation | 2024 |
| CAGR | 6.1% |
| Market Concentration | High |
| Major Players | Horizon Therapeutics, Immunovant, Viridian Therapeutics, Novartis, Apitope and Among Others |
please let us know !
Thyroid Eye Disease TED Market Analysis
The Global Thyroid Eye Disease (TED) Market is estimated to be valued at USD 2.71 Billion in 2025 and is expected to reach USD 4.10 Billion by 2032, growing at a compound annual growth rate (CAGR) of 6.1% from 2025 to 2032. The increasing prevalence of Graves' disease and hyperthyroidism across the globe is expected to drive the market growth during the forecast period.
The rising awareness about the condition and its treatment options along with increasing healthcare expenditure is further augmenting the market growth. Additionally, the expanding R&D activities for development of novel drug candidates for treatment of TED is also contributing to the increasing demand. Various pharmaceutical companies are investing heavily in clinical trials to develop effective therapeutic solutions for better management of TED symptoms.